Black Diamond Therapeutics, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (3)

Latest Posts

About This Stock More About This Stock
Black Diamond Therapeutics Stock Plunges On Safety Signals In Solid Tumor Study Of BDTX-189
Article By: Benzinga
Thursday, May 20, 2021 9:35 AM EDT
Black Diamond Therapeutics Inc reported initial data from the Phase 1 dose-escalation portion of the Phase 1/2 MasterKey-01 trial evaluating BDTX-189 in patients with advanced solid tumors.
In this article: BDTX
Read

Latest Tweets for $BDTX

No tweets yet!

PARTNER HEADLINES